20053322

Source:http://linkedlifedata.com/resource/pubmed/id/20053322

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004448, umls-concept:C0205210, umls-concept:C0332120, umls-concept:C0439661, umls-concept:C0596545, umls-concept:C1170049, umls-concept:C2603343
pubmed:dateCreated	2010-1-7
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9614685
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Dermatologic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/alefacept
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1203-4754
pubmed:author	pubmed-author:BissonnetteRobertR, pubmed-author:LandellsIanI, pubmed-author:SearlesGordonG, pubmed-author:ShearNeil HNH
pubmed:issnType	Print
pubmed:volume	13 Suppl 3
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	S107-12
pubmed:meshHeading	pubmed-meshheading:20053322-Canada, pubmed-meshheading:20053322-Clinical Trials as Topic, pubmed-meshheading:20053322-Dermatologic Agents, pubmed-meshheading:20053322-Humans, pubmed-meshheading:20053322-Morbidity, pubmed-meshheading:20053322-Psoriasis, pubmed-meshheading:20053322-Recombinant Fusion Proteins, pubmed-meshheading:20053322-Treatment Outcome
pubmed:year	2009
pubmed:articleTitle	Preface: real-world clinical experience with alefacept-the Amevive Wisdom Acquired from Real-World Evidence (AWARE) study.
pubmed:affiliation	Keystone Dermatology Institute, Edmonton, AB. gesearles@mac.com
pubmed:publicationType	Journal Article, Review, Research Support, Non-U.S. Gov't